CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...